Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100
-
最新报道：Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) has merged with MindWave Innovations Inc., combining a clinical-stage biotech firm with a provider of institutional Bitcoin treasury solutions. The merger aims to create a dual-growth enterprise, with Apimeds focusing on non-opioid pain therapies and MindWave contributing its AI-driven Bitcoin yield platform and $NILA token-powered ecosystem. E.F. Hutton served as the exclusive M&A advisor and placement agent for a concurrent PIPE financing of up to $100 million.
下一篇
Crypto derivatives exchange Bitnomial to launch cryptocurrency spot trading
- According to Crypto in America, on December 1st, the cryptocurrency derivatives exchange B...
24小时热点
热点专题
412759